A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy Cohort

scientific article published on 24 February 2020

A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy Cohort is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/IJMS21041536
P932PMC publication ID7073183
P698PubMed publication ID32102357

P50authorDomenico CorradoQ56529119
Perry M ElliottQ63377425
Riccardo BarianiQ89896241
Kalliopi PilichouQ116927285
Anna C FrigoQ44764874
Gaetano ThieneQ29840356
Barbara BauceQ29840367
Petros SyrrisQ30225443
P2093author name stringCristina Basso
Marco Cason
Rudy Celeghin
Joanna Jager
Maria Bueno Marinas
P2860cites work2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathQ55983200
A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signaling and miRNA dysregulationQ57283062
MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutationsQ62476607
Arrhythmogenic right ventricular cardiomyopathyQ64043862
Circulating microRNAs as novel biomarkers for dilated cardiomyopathyQ38440890
Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathyQ39033320
Knockdown of Plakophilin 2 Downregulates miR-184 Through CpG Hypermethylation and Suppression of the E2F1 Pathway and Leads to Enhanced Adipogenesis In Vitro.Q41009800
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humansQ41412919
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.Q44159535
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions.Q45944020
Circulating microRNAs in arrhythmogenic right ventricular cardiomyopathy with ventricular arrhythmia.Q47737719
What is an ROC curve?Q48114277
Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy.Q52954172
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease.Q54408211
The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cells.Q55457304
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.Q55638651
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1Q55670706
Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patientsQ21143782
Circulating microRNAs, potential biomarkers for drug-induced liver injuryQ24656209
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failureQ24673535
Arrhythmogenic cardiomyopathyQ26753099
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Q27860849
MicroRNAs: genomics, biogenesis, mechanism, and functionQ27861070
microRNAs: tiny regulators with great potentialQ28214699
MicroRNAs in CancerQ29615539
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).Q33164685
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy.Q33881246
Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?Q34395507
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyQ34465792
Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening programQ34571316
Right ventricular cardiomyopathy and sudden death in young peopleQ34687427
DIANA-miRPath v3.0: deciphering microRNA function with experimental supportQ35810103
Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathyQ36088154
Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarctionQ36511806
Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathyQ37010626
The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.Q37624877
MicroRNA and drug resistanceQ37751868
Circulating microRNAs: Association with disease and potential use as biomarkersQ37818867
Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?Q37981140
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.Q38119180
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseasesQ38418005
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesDESeq2Q113018293
P433issue4
P921main subjectbiomarkerQ864574
P577publication date2020-02-24
P1433published inInternational Journal of Molecular SciencesQ3153277
P1476titleA microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy Cohort
P478volume21

Search more.